These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7506116)

  • 1. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
    Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
    Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
    Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
    Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
    Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
    Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
    Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
    Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival.
    Tsugawa K; Fushida S; Yonemura Y
    Oncology; 1993; 50(6):418-25. PubMed ID: 7901825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma.
    Sato S; Ito K; Ozawa N; Yajima A; Sasano H
    Tohoku J Exp Med; 1991 Oct; 165(2):137-45. PubMed ID: 1687493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.
    Mizutani T; Onda M; Tokunaga A; Yamanaka N; Sugisaki Y
    Cancer; 1993 Oct; 72(7):2083-8. PubMed ID: 8397058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
    Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients.
    Tsuda H; Hirohashi S; Shimosato Y; Tanaka Y; Hirota T; Tsugane S; Shiraishi M; Toyoshima K; Yamamoto T; Terada M
    Jpn J Cancer Res; 1990 Apr; 81(4):327-32. PubMed ID: 1973161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
    Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
    Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.
    Hale RJ; Buckley CH; Fox H; Williams J
    J Clin Pathol; 1992 Jul; 45(7):594-6. PubMed ID: 1355495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neu (c-erbB-2), a tumor marker in carcinoma of the female breast.
    Maguire HC; Greene MI
    Pathobiology; 1990; 58(6):297-303. PubMed ID: 1981830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification.
    Shi H; Shao Y; Lu W; Lu B
    J Pathol Clin Res; 2021 Jan; 7(1):86-95. PubMed ID: 33089969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Overexpression of c-erbB-2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients].
    Meden H; Marx D; Rath W; Kuhn W; Hinney B; Schauer A
    Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):667-73. PubMed ID: 1360438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content.
    Prat J; Oliva E; Lerma E; Vaquero M; Matías-Guiu X
    Cancer; 1994 Sep; 74(6):1778-83. PubMed ID: 7915964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix.
    Altavilla G; Castellan L; Wabersich J; Marchetti M; Onnis A
    Eur J Gynaecol Oncol; 1996; 17(4):267-70. PubMed ID: 8856301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-erbB-2 Oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix.
    Oka K; Nakano T; Arai T
    Cancer; 1994 Feb; 73(3):664-71. PubMed ID: 7905364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.
    Zhang X; Wang CX; Zhu CB; Zhang J; Kan SF; Du LT; Li W; Wang LL; Wang S
    Int J Gynecol Cancer; 2010 Dec; 20(9):1597-603. PubMed ID: 21370603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.